Clinical Trial Update: A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver [Phase 1]

View source ↗

Summary

Phase I trial evaluating isolated hepatic perfusion with escalating-dose melphalan followed by postoperative hepatic arterial floxuridine and leucovorin in pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Drugs mentioned

• Floxuridine (floxuridine)
• Leucovorin (folinic acid)
• Melphalan (Melphalan)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colorectal Neoplasm, Liver Neoplasm | Phase 1 | Status: COMPLETED